Welcome to the 2019 BioProcess International Event Podcast Series!
Since its launch in 2003, the core mission of the BioProcess International brand (publication, event, and digital platforms) has remained unchanged: to constantly create and provide you with the most convenient and useful access to cutting-edge science and technologies, products and services, and the business relationships you need to more effectively develop safe, cost-efficient treatments for patients.
As the quality and quantity of content presented at BPI events continues to grow (no apologies!), it becomes almost impossible for attendees to experience everything on their priority lists onsite.
To help combat this challenge, BioProcess International created a three-part event extension program for the BPI Boston event allowing attendees to expand their experience and interaction pre-event (podcasts + eBook); onsite (Insider daily roundtables + BPITV); and post-event (highlights eBook).
Based upon its success, BioProcess International is pleased to expand the event extension program to all five BPI events in 2019. The goal remains the same: to highlight and provide you with access to insight, opinion, and perspective of industry VIPs while reinforcing the quality of information presented at BPI events.
This dedicated landing page is your portal to BPI Asia, BPI West, BPI Europe, BPI Boston, and BioProduction. Updated weekly, it will provide you with valuable information you can use to extend your event experiences.
Bookmark this page and reference throughout 2019!
Click to listen to the following industry experts as they discuss their experiences and predictions, while previewing BPIs 2019 events:
- Kim Raineri, Nikon Cell Innovation, “A Forward Look at the Future of Cell Therapy Manufacturing”
- Liming Shi, CMAB Biopharma, “Considerations and Strategies in Creation of GMP Master and Working Cell Banks
- Ohad Karnieli, Atvio Biotech, “Enabling Scale-Out of T-cell Manufacturing
- Chi Zhang, Ambrx, “Developing a Robust Downstream Process”
- Eugene Tung, Merck MSD, “Plug and Play for Single-Use Equipment”
- Parrish Galliher, GE Healthcare, “Next Generation Biomanufacturing”
- Peter Cramer, Exyte US, “Modular Platform Delivery Considerations”
- Margit Holzer, Ulysse Consult, “PAT Assisted Control Strategy for Continuous Downstream Processing”
- Martin Allen, Pfizer, “Rapid Development of Cell Lines Suitable for Commercial Manufacturing”
- Michael Backhaus, Shire, “Case Study: Global Implementation of Real Time Monitoring”
- Stefanos Grammatikos, UCB Pharma, “Bioprocess Innovations in the Era of Acceleration and Intensification”
- Prasad Pathange, Bayer US, "Approach to Identify and Control Product Attributes In Cell Culture Perfusion System"
- Cairan Brady, Bristol-Myers Squibb, "Strategies for Efficiency and Optimization"
- Zhiping Yao, JOINN Biologics US, "Case Study for Developability Assessment of Three Therapeutic Antibodies"
- Phillip Probert, Centre for Process Innovation, "From Sequence to Product in Hours – Cell-Free Expression for Next-Generation Therapeutics"
